...
首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Mantle cell lymphoma cells express high levels of CXCR, CXCR, and VLA-(CD9d): importance for interactions with the stromal microenvironment and specific targeting
【24h】

Mantle cell lymphoma cells express high levels of CXCR, CXCR, and VLA-(CD9d): importance for interactions with the stromal microenvironment and specific targeting

机译:套细胞淋巴瘤细胞表达高水平的CXCR,CXCR和VLA-(CD9d):与基质微环境和特异性靶向相互作用的重要性

获取原文
获取原文并翻译 | 示例

摘要

Mantle cell lymphoma (MCL) is characterized by an early, widespread dissemination and residual disease after conventional treatment, but the mechanisms responsible for lymphoma cell motility and drug resistance are largely unknown. There is growing evidence suggesting that chemokine receptors and adhesion molecules are critical for malignant B-cell trafficking and homing to supportive tissue microenvironments, where they receive survival and drug resistance sig-nals. Therefore, we examined chemokine receptor and adhesion molecule expression and function in MCL cells and their importance for migration and adhesion to marrow stromal cells (MSCs). We found that MCL cells display high levels of functional CXCR and CXCR chemokine receptors and VLA- adhesion molecules. We also report that MCL cells adhere and spontaneously migrate beneath MSCs in a CXCR- and VLA--dependent fashion (pseudoemperipolesis). Moreover, wedemonstrate that MSCs confer drug resistance to MCL cells, particularly to MCL cells that migrate beneath MSC. To target MCL-MSC interactions, we tested Plerixafor, a CXCR antagonist, and natalizumab, a VLA- antibody. Both agents blocked functional responses to the respective ligands and inhibited adhesive interactions between MCL cells and MSCs. These findings provide a rationale to further investigate the therapeutic potential of these drugs in MCL.
机译:幔细胞淋巴瘤(MCL)的特征是常规治疗后早期广泛传播和残留疾病,但是导致淋巴瘤细胞运动和耐药的机制尚不清楚。越来越多的证据表明,趋化因子受体和粘附分子对于恶性B细胞的运输和归巢到支持组织的微环境至关重要,在那里它们接受生存和耐药信号。因此,我们检查了趋化因子受体和粘附分子在MCL细胞中的表达和功能,以及它们对于迁移和粘附至骨髓基质细胞(MSC)的重要性。我们发现MCL细胞显示高水平的功能性CXCR和CXCR趋化因子受体和VLA-粘附分子。我们还报告说,MCL细胞以CXCR和VLA依赖性方式(假性经验极少)粘附并自发迁移至MSCs下。此外,我们证明了MSC对MCL细胞,特别是对在MSC下迁移的MCL细胞具有耐药性。为了靶向MCL-MSC相互作用,我们测试了CXCR拮抗剂Plerixafor和VLA抗体那他珠单抗。两种试剂均阻断了对各自配体的功能性反应,并抑制了MCL细胞与MSC之间的粘附相互作用。这些发现为进一步研究这些药物在MCL中的治疗潜力提供了依据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号